Latham & Watkins LLP

Chad Jennings helps FDA-regulated companies and financial institutions navigate complex transactions, particularly relating to life sciences and biotechnology.

Chad approaches each matter with a data-focused perspective and leverages a comprehensive understanding of his clients’ business objectives to assess risk associated with US Food and Drug Administration (FDA) regulation within the transactional context. He advises clients across the drug, biologics, medical device, food, and dietary supplement sectors in:

• • Capital markets offerings
  • Public and private financings
  • Mergers and acquisitions
  • Strategic transactions
  • Loan transactions and debt facilities
  • Public company representation matters

He draws on a breadth of regulatory advisory experience to advise clients on risks associated with pre-commercial product development and clinical and pre-clinical testing, product promotion and labeling, and product manufacturing and quality matters.

Chad served as a judicial intern for Judge Norman K. Moon at the US District Court for the Western District of Virginia. Before law school, Chad performed consulting work for a liberal arts college developing undergraduate business curriculum and research materials relating to finance and international investment.

A recognized thought leader, he participates with the Food and Drug Law Institute, including speaking at industry events.